HealthcareServices

Digital Biomarkers Market Outlook: Growth and Forecast Highlights 2030

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the digital biomarkers market from 2026–2035 with trusted insights from The Business Research Company

How much is the Digital Biomarkers Market valued at in 2026, and what valuation is forecast for 2030?

The digital biomarkers market has witnessed significant expansion in recent years. Its value is projected to increase from $4.96 billion in 2025 to $6.26 billion in 2026, representing a compound annual growth rate (CAGR) of 26.3%. Historically, this growth has been driven by several factors, including the rising adoption of consumer wearables, the expansion of mobile health applications, an increasing prevalence of chronic diseases, the availability of advanced biosensors, and a growing interest in preventive healthcare.

The digital biomarkers market size is projected to experience substantial growth in the upcoming years. It is set to expand to $15.77 billion by 2030, achieving a compound annual growth rate (CAGR) of 26.0%. This expansion over the forecast period is primarily fueled by factors such as increasing investments in digital health platforms, a rising demand for personalized healthcare monitoring, the broadening scope of predictive health analytics, deeper integration with electronic health records, and enhanced regulatory support for digital biomarkers. Prominent trends for this period involve the greater adoption of wearable health monitoring devices, an increased utilization of continuous remote patient monitoring, the growing integration of AI-based health analytics, the expansion of sensor-based disease tracking, and an intensified focus on real-time health data collection.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19397&type=smp

What Drivers Are Influencing The Growth Of The Digital Biomarkers Market?

The escalating occurrence of chronic diseases is anticipated to drive the expansion of the digital biomarkers market in the future. These diseases are enduring health conditions characterized by gradual progression and prolonged duration, frequently lifelong. The rise in chronic diseases, including age-related issues like osteoarthritis, Alzheimer’s disease, and heart disease, combined with a diet high in processed foods and insufficient physical activity, elevates the likelihood of developing these conditions. Digital biomarkers find application in chronic disease management by offering real-time tracking of health metrics and disease advancement, thereby facilitating tailored and prompt interventions. For example, in April 2025, data from the Centers for Disease Control and Prevention, a US-based federal public health agency, indicated that 76.4% of US adults, totaling approximately 194 million individuals, reported at least one chronic condition in 2023. The prevalence was observed to be 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Consequently, the increased occurrence of chronic diseases is set to boost the expansion of the digital biomarker market.

How Is The Digital Biomarkers Market Organized Into Various Segments?

The digital biomarkers market covered in this report is segmented –

1) By Type: Wearable, Mobile Based Applications, Sensors, Other Types

2) By Clinical Practice: Diagnostic Digital Biomarkers, Monitoring Digital Biomarkers, Predictive And Prognostic Digital Biomarkers, Other Clinical Practices

3) By Application: Oncology, Metabolic Disease, Neurological Disease, Cardiac Disease, Other Applications

4) By End User: Healthcare Companies, Healthcare Providers, Payers, Other End Users

Subsegments:

1) By Wearable: Smartwatches, Fitness Trackers, Wearable ECG Monitors, Continuous Glucose Monitors

2) By Mobile Based Applications: Health Monitoring Apps, Digital Therapeutics Apps, Symptom Tracking Apps, Remote Patient Monitoring Apps

3) By Sensors: Biosensors, Motion Sensors, Environmental Sensors, Implantable Sensors

4) By Other Types: Voice Biomarkers, Digital Imaging Biomarkers, Behavioral Biomarkers, Telemedicine Tools

Which Innovation Trends Are Advancing Developments Within The Digital Biomarkers Market?

Leading firms within the digital biomarker market are employing a strategic partnership strategy to broaden their scope and improve their range of services. Such a partnership generally describes a cooperative arrangement involving multiple entities that unite their resources, knowledge, and work toward shared aims or targets. As an illustration, during September 2023, ProofPilot, a US-based clinical trial automation provider, established a strategic collaboration with Eli Lilly and Company, a US-based pharmaceutical company. This was done to incorporate Lilly’s inventive, patent-pending sensor cloud platform, Magnol.AI, into ProofPilot’s existing technology. Magnol.AI stands as an advanced platform, developed for managing high-frequency sensor data with remarkable security and simplicity. The objective of this joint effort is to improve the conduct of premium digital health research, thereby speeding up pre-competitive biomedical investigations. Through this integration, researchers are enabled to leverage real-time data science functionalities and extract profound insights from sensor data, correlating with clinician and patient-reported outcomes to further digital health and biomarker research.

Who Are The Major Companies Operating In The Digital Biomarkers Market?

Major companies operating in the digital biomarkers market are Pfizer Inc, Bayer AG, F Hoffmann-La Roche Ltd, Eli Lilly and Company, Koninklijke Philips NV (Philips), GE Healthcare, Biogen Inc, Garmin Ltd., Clario, Verily Life Sciences LLC, Altoida Inc., BioSerenity, Oura Health Oy., Evidation Health Inc, AliveCor Inc, Empatica Inc, ActiGraph LLC, VivoSense Inc, BioSensics LLC, Koneksa Health Inc, ATCOR Medical Pty Ltd, Brainomix Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/digital-biomarkers-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Digital Biomarkers Market?

North America was the largest region in the digital biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Digital Biomarkers Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19397&type=smp

Browse Through More Reports Similar to the Global Digital Biomarkers Market 2026, By The Business Research Company

Digital Payments Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-payments-global-market-report

Digital Publishing Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-publishing-global-market-report

Digital Pc Games Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-pc-games-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795